| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.4M | — |
| Cost of Revenue | $422K | — |
| R&D Expense | $150.5M | +3.0% |
| SG&A Expense | $197.6M | +46.8% |
| Operating Income | -$343.0M | -22.2% |
| Net Income | -$325.1M | -17.2% |
| EPS (Basic) | -$5.15 | +1.2% |
| EPS (Diluted) | -$5.15 | +1.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.1M | +160.9% |
| Accounts Receivable | $5.9M | — |
| Inventory | $3.1M | — |
| Current Assets | $500.9M | -16.5% |
| Total Assets | $725.8M | +15.2% |
| Current Liabilities | $78.2M | +53.1% |
| Total Liabilities | $99.6M | +38.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$222.8M | -37.9% |
| Capital Expenditures | $7.4M | -27.6% |
| Investing Cash Flow | $34.8M | +116.1% |
| Financing Cash Flow | $296.6M | -12.9% |
| Free Cash Flow | -$230.2M | -34.0% |
| Stockholders' Equity |
| $626.2M |
| +12.2% |